Statistics for Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
Total visits
| views | |
|---|---|
| Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | 1 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 1 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| Zambrano2022Effectiveness-PubP.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 1 |
Top city views
| views | |
|---|---|
| Indianapolis | 1 |